Literature DB >> 21858386

The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients.

Gamal Elawa1, Ahmad M AoudAllah, Ali E Hasaneen, Amr M El-Hammady.   

Abstract

OBJECTIVE: To evaluate the predictability of estimation of serum mannan-binding lectin (MBL) for the presence of infectious complications in type 2 diabetes mellitus (T2DM) and its relation to the extent of diabetes control.
METHODS: A comparative cross-sectional study was conducted at the Departments of Clinical Pathology and Internal Medicine, Faculty of Medicine, Benha University, Benha, Egypt from October 2009 to December 2010. Sixty adult patients with T2DM were divided into 2 groups: Group B and Group C and Group A as the control group. All subjects evaluation of insulin sensitivity (Homeostasis Model Assessment of Insulin Resistance [HOMA-IR]), and blood samples for estimation of fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c) and serum insulin, urea, creatinine, C-reactive protein (CRP), and MBL.
RESULTS: All patients had significantly increased FBG, serum insulin, HOMA-IR index, serum CRP and MBL levels compared with the control group, with significantly higher levels in Group C. Levels of HbA1c, serum urea, and creatinine were significantly higher in patients than controls. There was a positive significant correlation between serum MBL and FBG, HOMAIR index, serum urea, creatinine, and CRP levels. The receiver operating characteristics curve analysis in infectious cases revealed high FBG, HOMA-index and serum levels of HbA1c, CRP, and MBL, while regression analysis defined elevated serum MBL levels as a significant independent predictor for the presence of infection.
CONCLUSION: Elevated serum MBL in T2DM patients indicated a possible poor diabetic control and bad progression of the disease with possibility of the presence, or development of diabetic nephropathy especially in combination with elevated serum CRP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858386

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  6 in total

1.  Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes.

Authors:  Fang-Yu Song; Meng-Hai Wu; Li-Hua Zhu; Zhi-Qiang Zhang; Qin-De Qi; Chang-Li Lou
Journal:  Mol Neurobiol       Date:  2014-10-25       Impact factor: 5.590

2.  P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report.

Authors:  Hong Wu; Yijun Nie; Huangui Xiong; Shuangmei Liu; Guilin Li; An Huang; Lili Guo; Shouyu Wang; Yun Xue; Bing Wu; Lichao Peng; Miaomiao Song; Guodong Li; Shangdong Liang
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

3.  High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes.

Authors:  Qian Huang; Guilian Shang; Haohua Deng; Jie Liu; Yan Mei; Yancheng Xu
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

4.  Mannose-binding lectin activation is associated with the progression of diabetic nephropathy in type 2 diabetes mellitus patients.

Authors:  Kedan Cai; Yanhong Ma; Junni Wang; Wanyun Nie; Junmin Guo; Minqiao Zhang; Yi Yang; Jianghua Chen; Fei Han
Journal:  Ann Transl Med       Date:  2020-11

5.  Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients.

Authors:  Miklós Káplár; Shah Sweni; Julianna Kulcsár; Barbara Cogoi; Regina Esze; Sándor Somodi; Mária Papp; László Oláh; Mária Tünde Magyar; Katalin Szabó; Katalin Réka Czuriga-Kovács; Jolán Hársfalvi; György Paragh
Journal:  J Diabetes Res       Date:  2015-11-10       Impact factor: 4.011

6.  Association of levels of mannose-binding lectin and the MBL2 gene with type 2 diabetes and diabetic nephropathy.

Authors:  Nana Zhang; Maoqiang Zhuang; Aixia Ma; Guochang Wang; Ping Cheng; Yajun Yang; Xiaofeng Wang; Juan Zhang; Xingdong Chen; Ming Lu
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.